RP-3500
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for RP-3500, covering 2025-06-03 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors [Phase 1]